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Abstract Over the past two decades, many environmen-
tally sustainable sample-preparation techniques have
been proposed, with the objective of reducing the use
of toxic organic solvents or substituting these with
environmentally friendly alternatives. Microextraction
techniques (MEs), in which only a small amount of
organic solvent is used, have several advantages, includ-
ing reduced sample volume, analysis time, and operat-
ing costs. Thus, MEs are well adapted in bioanalysis, in
which sample preparation is mandatory because of the
complexity of a sample that is available in small quan-
tities (mL or even μL only). Capillary electrophoresis
(CE) is a powerful and efficient separation technique in
which no organic solvents are required for analysis.
Combination of CE with MEs is regarded as a very
attractive environmentally sustainable analytical tool,
and numerous applications have been reported over the
last few decades for bioanalysis of low-molecular-
weight compounds or for peptide analysis. In this paper
we review the use of MEs combined with CE in bio-
analysis. The review is divided into two sections: liquid
and solid-based MEs. A brief practical and theoretical
description of each ME is given, and the techniques are
illustrated by relevant applications.
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USAEME Ultrasound-assisted emulsification
microextraction
Introduction
The overall analytical procedure includes several consecu-
tive steps—sampling, sample storage, sample preparation,
separation of target analytes, detection, and data treatment.
For analysis of complex samples and matrices, for example
biological, environmental, or food analysis, the sample
preparation is of utmost importance for obtaining the analy-
tes of interest in a suitable injection solution able to provide
reliable and accurate results. Sample preparation has sub-
stantial objectives before sample injection, including:
1. reducing or eliminating matrix interferents or undesired
endogenous compounds;
2. increasing selectivity for targeted analyte(s);
3. preconcentrating the sample to enhance sensitivity; and
4. stabilizing the sample by reconstituting it in an inert
solvent.
Although great improvements have been made in the
development of fast separation techniques, sample pretreat-
ment remains the most time-consuming step, accounting for
ca two thirds of the entire analytical procedure [1]. In
addition, because of the lack of automation of several offline
procedures, sample preparation is also regarded as a primary
source of analytical errors that can significantly affect the
throughput [2].
Sample preparation can be based either on selective
methods, e.g., the widely used solid-phase extraction
(SPE) and liquid–liquid extraction (LLE), or non-selective
methods, e.g., using membrane techniques or protein pre-
cipitation (PP). A common feature of all these conventional
sample-preparation techniques is the relatively high con-
sumption of solvents that are environmentally hazardous
and health risks for humans. The advent of the concept of
“green chemistry” at the beginning of the 1990s emphasized
the need for non-toxic and environmentally friendly analyt-
ical procedures. The concept also promoted the use of
environmentally sustainable sample-preparation methods
with the development of solvent-free or miniaturized extrac-
tion methods [3, 4]. Different approaches can be envisaged
when developing environmentally sustainable sample
preparation:
1. solventless procedures [5, 6];
2. substitution of organic solvents with less-toxic alterna-
tives, for example use of supercritical-fluid extraction,
cloud-point extraction, subcritical water extraction, or
extraction with ionic liquids [7, 8]; or
3. use of microextraction techniques (MEs), in which min-
iaturization of the extraction procedure not only mini-
mizes the use of organic solvents but also the sample
volume required.
MEs are defined as non-exhaustive procedures that use
very small volumes of the extracting phase and for which
the volume of sample is relatively large compared with that
of the extracting phase [9]. MEs reduce or eliminate the
consumption of solvents while simultaneously reducing
sample volume, analysis time, and operating costs [10].
Many techniques have been developed over the last few
decades for a variety of applications, i.e., in environmental
analysis (pesticides, hormones) [11–13], food analysis [11,
13–15], and bioanalysis [16, 17] for clinical, toxicological
and forensic purposes [18, 19] or doping analysis [20]. In
bioanalysis, often only small amounts of the sample are
available, typically in the mL range for urine and in the
μL range for serum or plasma or alternative matrices, for
example sweat, saliva, or tears. Because of the complexity
of theses matrices and the low concentrations of the target
analytes compared with endogenous interferents, sample
preparation is mandatory, and MEs are particularly well
adapted for this purpose.
A variety of analytical techniques, including separation-
based approaches, can be implemented in combination with
MEs in bioanalysis. Non-polar and volatile compounds are
conveniently analyzed by gas chromatography (GC), where-
as liquid chromatography (LC), including ultra-high-
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pressure liquid chromatography (UHPLC), is extensively
used in bioanalysis for both quantitative and qualitative
purposes, because of its wide applicability to a large number
of compounds with different physicochemical properties.
Capillary electrophoresis (CE) is another powerful separa-
tion technique that is often used in bioanalysis, because of
its high separation efficiency. As very small amounts of (μL
range) or no organic solvents are required for CE analysis,
its use in combination with ME techniques is regarded an
attractive, environmentally sustainable analytical tool.
Extracts can be directly injected for analysis, or evaporated
and reconstituted in a very small volume. Because a few nL
of sample is injected in CE, very high preconcentration
factors (PFs) can be achieved, enhancing the overall sensi-
tivity, which is a disadvantage of the capillary format.
Applications of ME techniques before to CE analysis
have been reported over the past few decades in bioanalysis
of low-molecular-weight compounds or small peptides. In
this paper we review the MEs used in bioanalysis and
combined with CE. It is divided into two sections: liquid
and solid-based MEs. MEs are classified according to their
extraction principle and improvement of extraction perfor-
mance. A brief description and the theoretical concepts of
each ME technique are introduced and discussed, and illus-
trated by relevant applications.
Liquid-based microextraction techniques
LLE, which involves partition of analytes between an aque-
ous sample and water-immiscible organic solvent, has been
widely used in bioanalysis because of its simplicity and ease
of implementation. LLE suffers from major drawbacks, for
example emulsion formation at the interface of the immis-
cible phases, lack of selectivity (co-extraction of endoge-
nous interferents), lack of automation, and use of large
sample volumes and large amounts of toxic organic solvents
that are environmentally harmful (up to 10 mL per mL of
sample) [10, 16, 17, 21].
New methods based on the LLE principle or with original
set-ups have been developed during the last two decades to
overcome these drawbacks. Miniaturization of LLE has led
to several new liquid-based ME techniques in which the
total volume of organic solvent required has been reduced
to the sub-mL level.
In 1996, Cantwell and co-workers [22] and Dasgupta and
co-workers [23] were the first to propose the use of a solvent
drop in the μL range as extractant, laying the foundation for
liquid-phase microextraction (LPME). Cantwell and co-
workers used an 8-μL drop of n-octane held at the end of a
Teflon rod to extract 4-methylacetone fromwater [22], where-
as Dasgupta and co-workers extracted sodium dodecyl sulfate
(SDS) from a water sample with only 1.3 μL chloroform [23].
A variety of liquid MEs based on LPME were subsequently
developed, leading to a large selection of miniaturized techni-
ques that are still evolving. A schematic diagram of these
techniques, based on their principle of extraction, is given in
Fig. 1. All of the bioanalytical applications that use LPME-
based techniques before CE are listed in Table 1.
Liquid-based ME techniques are derived either from
single-drop microextraction (SDME), in which a single drop
of water-immiscible solvent suspended from the tip of a
syringe is immersed in the aqueous sample, or hollow-
fiber liquid-phase microextraction (HF-LPME), in which a
hollow polymeric fiber is used as a support for the acceptor
(aqueous or organic) phase.
Single-drop microextraction (SDME)
SDME was introduced in 1997 by Jeannot et al. and He et
al. [24, 25]. In the first study, a 1-μL drop of n-octane was
suspended in a stirred aqueous sample from the tip of a
microsyringe needle. After a few minutes, the drop was
retracted into the needle and injected directly for gas chro-
matographic (GC) analysis [24]. He and Lee used the same
method with a 1-μL drop of toluene that was immersed in
the aqueous sample for 15 min before retraction and injec-
tion [25]. SDME uses very small amounts of organic ex-
traction solvents, which enables important PFs to be
achieved. The main problems with this method are lack of
droplet stability at high stirring speeds and the high manual
dexterity required. Moreover, SDME is only suitable for
relatively non-polar analytes and suffers from low recovery
and repeatability. Therefore, SMDE was regarded as be not
suitable for biological matrices, in which an extra filtration
step is necessary [2, 11, 26]. Many derived techniques based
on SDME were thus proposed (Fig. 1), including liquid–
liquid–liquid microextraction (LLLME) or dispersive liq-
uid–liquid microextraction (DLLME), and used in combi-
nation with CE to obtain sufficient selectivity, sensitivity,
and repeatability in bioanalysis.
Liquid-liquid-liquid microextraction (LLLME)
LLLME, also referred to as LPME by back-extraction, was
first introduced in 1998 by Ma and Cantwell [27] and is
particularly suitable for water-soluble analytes, for example
ionizable compounds. In LLLME, the targeted analytes are
first extracted from the aqueous sample (donor) into a water-
immiscible organic phase (acceptor I) and then back-
extracted into a separate aqueous phase (acceptor II). The
transfer occurs by manipulating the pH in the donor and
acceptor phases. LLLME is particularly suitable for CE
analysis, because of the direct injection of the aqueous
acceptor phase into the system.
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Extraction improvement
The particular configuration of CE enables on-line or in-line
back-extraction to be performed. On-line back-extraction
(OLBE) with field-amplified sample injection (FASI) was de-
veloped for analysis of cocaine and thebaine in urine samples
[28]. Eight milliliters of urine were placed in a vial, and a 2-μL
drop of chloroform was generated at the tip of a syringe and
immersed in the sample. After extraction for 5 min, with
stirring, the chloroform drop was retracted and transferred to
another vial that was sealed with 40 μL acidified water for
back-extraction. OLBE was performed by carefully immersing
the capillary tip in the water plug. During high-voltage appli-
cation, FASI occurred, and charged analytes moved rapidly
from the organic phase to the capillary, stacked at the boundary
with the high-conductivity background electrolyte (BGE).
MeCN (20 %, v/v) was also added to the water plug to reduce
conductivity, thus substantially enhancing sensitivity.
In-line back-extraction (ILBE) was performed with a wa-
ter–organic drop hanging at the tip of the capillary [29]. In this
case, the capillary was filled with acidic BGE (acceptor
phase), and then 13 nL octanol was injected. After injection,
the tip of the capillary was immersed in the urine sample,
which had previously been made alkaline, and a backpressure
was applied from the outlet to the inlet, forming a small drop
of the acceptor phase that was covered with a thin organic
layer hanging at the tip. After extraction, the acceptor phase
was injected into CE. This configuration is well adapted to
saline samples, for example urine; however, it is hardly
achievable on a commercial CE instrument [26].
To enhance the transfer of analytes between the sample and
organic phase, use of carriers with LLLME was envisaged by
Choi et al. in 2011, in so-called carrier-mediated single-drop
microextraction (CM-SDME) [30]. Amino acids were extracted
from urine by use of nonane-1-sulfonic acid as carrier. Addition
of this negatively charged carrier at a low pH with positively
charged amino acids enabled the formation of a neutral ion pair
that could be extracted into the organic phase. Octanol was
chosen as the extracting phase because of its capacity to form
hydrogen bonds with the ion pair. CM-SDME enabled 120-fold
sensitivity improvement compared with CZE without SDME.
Drop stability improvement
Although the above-mentioned LLLME technique [28] has
been shown to be fast, simple, inexpensive, and sensitive, it
clearly suffers from drop instability. Therefore, in the same year,
Fang et al. developed centrifuge microextraction (CME), which
combines desalting, preconcentration, and removal of macro-
molecular contaminants and other interfering components in a
single step [31]. After pH adjustment and addition of NaCl for
the salting-out effect, 1 mL urine was mixed with 50 μL toluene
and centrifuged at 10,000 rpm for 10 min. A lower-density
water-immiscible solvent was chosen so the acceptor phase
was at the top of the sample. During centrifugation, the centrif-
ugal force applied by the rotor led to sedimentation of
Liquid-based 
ME 
SDME HF-LPME 
LLLME DLLME 
OLBE 
ILBE 
CM-SDME 
USAEME 
µ-SLM 
HF-LLLME 
EME 
DMD-LPME 
PT-LLLME 
CM-LPME 
HF-HS-LPME 
CME 
DSDME 
HS-SDME 
+ - 
Fig. 1 Classification of liquid-
based microextractions used in
combination with CE. Light
gray, aqueous phase; dark
gray, organic phase; cross
hatched, membrane or fiber
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macromolecules whereas diffusion enabled transfer of the tar-
geted compounds to the acceptor phase. The supernatant was
directly injected in CE–UV with FASI, leading to a limit of
detection (LOD) of 0.15 ngmL−1. CME has also been used for
analysis of steroids (e.g., testosterone and progesterone) in urine
by micellar electrokinetic chromatography (MEKC) [32].
In 2006, Yangcheng et al. proposed directly suspended
droplet microextraction (DSDME) to further improve drop
stability. Here, the microdroplet of solvent is suspended at the
top in the center of the aqueous sample before sampling [33]. A
symmetrical rotated flow field is created by a stirring bar that is
placed on the bottom of the cylindrical sample cell to ensure the
droplet suspension. This rotation also intensifies transfer of
analytes to the inside of the droplet. DSDME has been com-
bined with single-drop back-extraction and CE for analysis of
alkaloids in urine samples [34]. After the first extraction in a
large microdrop (approx. 60 μL) of n-octanol, alkaloids were
back-extracted in a 1-μL aqueous drop that was immersed in
the organic phase droplet. PFs of greater than 500 were
achieved with lower solvent consumption and shorter extrac-
tion time than those of LLLME.
Introduced by Theis et al. [35] in 2001, headspace single-
drop microextraction (HS-SDME) has excellent extraction and
preconcentration performance for volatile compounds. With a
suspended drop in the gaseous phase (headspace), this method
enables rapid stirring of an aqueous sample, for a shorter anal-
ysis time, without affecting drop stability. Moreover, non-
volatile matrix interferences are reduced or eliminated [19, 26,
36]. HS-SDME has also been used in combination with CE
analysis with in-drop derivatization. Free cyanide was solvent-
lessly extracted from smoker and non-smoker urine and saliva
[37], using water to extract volatile and water-soluble com-
pounds. An aqueous 5-μL drop containing Ni(II)–NH3 as de-
rivatization agent for CE analysis was used for the extraction. In
the basic acceptor phase, cyanide reacted with Ni2+ to form a
stable Ni(CN4)
2− complex analyzed by CE–UV at 257 nm.
Water-based HS-SDME was very selective, despite the rather
universal detection wavelength, because the non-volatile inter-
ferents remained unaffected in the sample. HS-SDME with a
chloroform–MeOH mixture as extracting drop has also been
used to extract seven toxic compounds from horse urine samples
at room temperature, before analysis by open tubular capillary
electrochromatography (OT-CEC) [38].
Dispersive liquid–liquid microextraction (DLLME)
In DLLME, which was first introduced by Rezaee et al. in
2006, the extracting solvent is mixed with a dispersing
solvent that is miscible both with the former and with the
aqueous sample [39]. The mixture is rapidly injected into
the sample with a syringe, producing high turbulence that
leads to the formation of tiny droplets. Because of the large
surface area between the extracting droplets and sample, the
extraction time is drastically reduced. After centrifugation,
the sedimented phase at the bottom of the tube is collected
and either injected directly or evaporated to dryness before
reconstitution and injection.
DLLME combined with CE and time-of-flight mass
spectrometry (TOF/MS) was used for qualitative toxicolog-
ical screening of urine samples [40]. An experimental de-
sign strategy was used to increase the extraction efficiency.
CH2Cl2 and i-PrOH were selected as extracting and dispers-
ing solvents, respectively, with a total volume of 2 mL.
Because of a high PF (more than 130) and the high sensi-
tivity and selectivity of CE–TOF/MS, LODs down to the
sub-ngmL−1 range were obtained for more than 30 toxic
basic compounds and their main metabolites and confirmed
by real case analysis.
Extraction improvement
One of the main disadvantages of DLLME is the need to use a
dispersing solvent to create an emulsion, which can reduce the
partition coefficient of the analytes in the extracting phase and
increase total solvent consumption. The dispersing solvent can
be substituted by using ultrasound to achieve ultrasound-
assisted emulsification-microextraction (USAEME) [41].
Based on previous work on ultrasound-assisted sample prepa-
ration [42], USAEME is beneficial for promoting emulsion
formation, extending the contact surface between both phases,
and reversing the potential coalescence effect. Increasing the
temperature also enables efficient and fast extraction [41]. A
serial USAEME procedure was developed for analysis of cre-
atinine and serotonin in urine samples [43]. Five hundred
microliters of ethyl acetate was added to 5 mL urine and the
sample was immersed in an ultrasonic bath for 5 min at 40 Hz.
The emulsion was centrifuged, and the organic supernatant
mixed with 25 μL 0.1 molL−1 HCl. Back-extraction was
performed by 3-min ultrasonication at 40 Hz. After centrifuga-
tion, the sedimented acceptor phase was collected and injected
by use of a pH-mediated stacking procedure. With serial
USAEME and sample stacking, a PF of 360 was obtained for
serotonin.
Hollow-fiber-based liquid-phase microextraction
(HF-LPME)
The chemical principle of HF-LPME is derived from
supported-liquid membrane (SLM) extraction, which was
previously developed by Jönsson and coworkers [44]. In
SLM, analytes are extracted through a flat porous polymeric
membrane sheet with continuous sample pumping. SLM
was first miniaturized (“μ-SLM”) in 1996 by Jönsson and
coworkers [45] and applied to the analysis of bambuterol in
plasma samples that were continuously pumped to on-line
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SLM–CZE [46]. An in-line SLM approach with a Teflon
micromembrane unit glued to a plastic microtube integrated
in the CE vial was developed by Nozal et al. for analysis of
nitroimidazoles in pig liver tissues homogenized in water
[47]. Very recently, Kuban and Bocek proposed on-line μ-
SLM-CE with a planar SLM screwed between two PTFE
blocks to determine amino acids in plasma or serum [48].
This home-built set-up did not require additional pumps.
In contrast to μ-SLM, HF-LPME is performed without
any pumping device. It was introduced in 1999 by Pedersen-
Bjergaard and Rasmussen [49]. In HF-LPME, the extracting
phase is placed inside the lumen of a porous polypropylene
fiber (pore size 0.2 μm) of minimal dimensions used in
different configurations, e.g., U-shaped, rod-like, 96-well,
or directly connected to a microsyringe [21, 44]. The poly-
meric fiber, which is compatible with a broad range of
organic solvents, enables use of a larger extraction volume
compared with SDME and acts as a physical barrier between
phases, avoiding undesirable emulsions and enhancing
cleanup efficiency [19]. HF-LPME can be performed in
either two or three-phase systems. In three-phase systems,
referred to as hollow-fiber-based liquid–liquid–liquid
microextraction (HF-LLLME), supported liquid membrane
microextraction (SLMME), or, rather improperly, LPME,
the analytes are extracted from the aqueous sample through
the organic film (a few microliters) that is present in the
pores of the aqueous acceptor phase in the lumen of the
hollow fiber. HF-LLLME is well suited to extraction of
polar or ionizable compounds and particularly suitable for
CE analysis.
Hollow-fiber-based liquid–liquid–liquid microextraction
(HF-LLLME)
Pedersen-Bjergaard and Rasmussen with co-workers have
developed many applications of HF-LLLME in combination
with CE. Methamphetamine [49–51], non-steroidal anti-
inflammatory drugs (NSAIDs) [52], naproxen [50], citalo-
pram and metabolites [51, 53, 54], and a variety of basic
drugs [55] have been successfully extracted from urine and
serum or plasma. HF-LLLME has also been used to extract
antidepressants from human milk [56]. Human milk is char-
acterized by high protein, fat, and carbohydrate content,
which can affect the recovery and repeatability of the ex-
traction procedure. Because of interaction of antidepressants
with fat and proteins, recovery from milk was lower than
from water. Thus, PP was implemented, with addition of
hydrochloric acid to the sample before centrifugation and
extraction to remove the fat-rich layer and release unbound
drugs, leading to recovery of 50–70 %. Li et al. used HF-
LLLME for extraction of organomercury from human hair,
with the fiber pores impregnated with bromobenzene [57].
Hair samples were first rinsed with detergent and acetone,
and air-dried before cutting and leaching. The leached solu-
tion was centrifuged, and the supernatant collected for HF-
LLLME. An aqueous acceptor phase containing L-cysteine
for organomercury complexation was injected with large
volume sample stacking (LVSS), enabling enrichment of
more than 4,000.
Extraction improvement
A new LPME-based technique referred to as phase-transfer-
based liquid–liquid–liquid microextraction (PT-LLLME)
was developed in 2011 by Li et al. for extraction of organic
and inorganic mercury from hair [58]. In this homemade set-
up, a porous, hydrophilic, nylon-membrane-supported ex-
traction tip was built and used with 15 μL aqueous acceptor
phase. MeCN and dodecylamine were added to the sample
before extraction as intermediate solvent and complexing
reagent, respectively. MeCN improved the dispersion of
water-immiscible dodecylamine in the aqueous sample to
ensure maximum contact with the mercury. Compared with
mercury extraction by HF-LLLME, PT-LLLME provided
the potential for simultaneous speciation of inorganic and
organic mercury and improved the sensitivity with enhanced
extraction efficiency.
Use of carriers, also used in SDME (section “Liquid–
liquid–liquid microextraction (LLLME)”, subsection “Ex-
traction improvement”), was first introduced in 2003 by Ho
et al. in the so-called carrier-mediated liquid-phase micro-
extraction (CM-LPME) to enhance extraction recovery of
polar or ionic analytes [59]. The carriers form lipophilic
complexes with the target analytes, promoting the transport
of the analytes through the organic membrane. Polar basic
compounds could be extracted from plasma and urine sam-
ples, through the 1-octanol layer into the aqueous acceptor
phase, with good recovery, after addition of sodium octa-
noate (ion-pair reagent) to the sample. The pH of the sample
had to be adjusted so the analytes and carrier were ionized in
such a way to enable the formation of ion-pair complexes
that could diffuse through the membrane. Numerous car-
riers, including organic borates, phosphates, sulfates, and
carboxylic acids, were investigated at different concentra-
tions with a special emphasis on their compatibility with
plasma samples [60]. Bromothymol blue (sulfate carrier)
resulted in the best recovery from the plasma samples.
Interestingly, recovery was enhanced when sodium sulfate
was added to the sample to reduce matrix effects.
In 2005, Lee and coworkers developed hollow-fiber-
protected headspace liquid-phase microextraction (HF-HS-
LPME), in which the hollow fiber protected and held the
extractant droplet in the headspace [61]. The surface area
between the organic and acceptor phases was dramatically
enhanced compared with HS-SDME (section “Liquid–
liquid–liquid microextraction (LLLME)”, subsection “Drop
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stability improvement”), increasing the extraction efficiency.
HS-HF-LPME was used to extract free cyanide from urine
and saliva with a simultaneous in-fiber derivatization to form a
stable Ni(CN)4
2− complex. Lower LODs (0.01 μmolL−1 ver-
sus 0.08 μmolL−1) and similar recovery (90–105 %) were
obtained compared with HS-SDME [37]. HF-HS-LPME is an
effective alternative to HS-SDME for quantitative analysis of
volatile compounds.
Throughput improvement
In 2006, Pedersen-Bjergaard and Rasmussen proposed use
of an electrically-driven force to aid extraction of charged
compounds and to speed HF-LLLME [62, 63]. This tech-
nique was first referred to as “electro membrane isolation”
(EMI) and was later termed electro membrane extraction
(EME). Two platinum electrodes are placed in the sample
solution and in the aqueous acceptor phase in the lumen of
the fiber. A potential (typically 300 V) is applied, and
charged analytes migrate through the membrane toward
the oppositely charged electrode in the acceptor solution in
less than 5 min. Interesting clean-up, enrichment, and isola-
tion of basic compounds with 2-nitrophenyl octyl ether
(NPOE) as organic solvent were observed with high extrac-
tion recovery (>70 %) from plasma and urine.
Pedersen-Bjergaard, Rasmussen, and co-workers showed
the benefits of EME for analysis of basic drugs (e.g., anal-
gesics, antidepressants, and antiepileptics) in plasma and
whole blood [64], or urine and human milk [65]. They also
evaluated the potential of EME as a fast and effective
extraction technique for peptides (angiotensin as the model
peptide) in plasma [66].
Other groups evaluated EME for a variety of applica-
tions, for example extraction of amino acids [67], lithium
[68], amlodipine enantiomers [69], and trimipramine enan-
tiomers [70] from urine, plasma or serum, or whole blood.
A miniaturized form of EME, termed drop-to-drop
LPME, has been proposed for extraction of basic drugs from
urine and plasma [71]. A small well with a volume of 15 μL
was pressed into 5-cm2 aluminium foil connected to the
power supply’s positive outlet. The well, containing 10 μL
sample, was covered with the membrane and a 10-μL ac-
ceptor droplet. Recovery of 33–47 % was obtained with
excellent clean-up, short extraction time, and very low sol-
vent and sample consumption.
In 2010, this miniaturization was built upon with the de-
velopment of on-line droplet–membrane–droplet LPME
(DMD-LPME) [72]. The extraction set-up was the same as
in Ref. [71] and was combined on-line with microchip capil-
lary electrophoresis (MCE) with fluorescence detection.
DMD-LPME was directly compatible with MCE because of
the very low acceptor phase volume. After 5 min, analysis of
two model analytes spiked in blank urine led to recovery of 15
and 25 %, which was lower than from aqueous standards.
However, DMD-LPMEwas found to be competitive for high-
throughput analysis, because of the high extraction speed and
its feasibility for coupling with rapid microfluidic analysis.
DMD-LPME has also been combined with MCE for drug
metabolism studies with ESI-triple quadrupole MS detection
[73]. Compared with SPE, DMD-LPME enabled faster anal-
ysis and higher selectivity for phase I metabolites.
Solid-based microextraction techniques
SPE is the most widely used technique for clean-up, precon-
centration, and selective extraction. Over the last few decades, a
large variety of commercial silica-based or polymeric sorbents
(e.g., normal-phase, reversed-phase, ion-exchange mode,
mixed-mode, and, more recently, molecularly imprinted poly-
mers (MIP), monoliths, and restricted-access media, RAM)
have been developed to enable extraction of a variety of analy-
tes with divergent chemical structure and polarity, with careful
attention to higher loading capacity and efficiency. SPE can be
automated easily, furnishes high recovery, and is claimed to be
highly selective in relation to matrix interferences [2, 17].
However, conventional SPE has some limitations, for example
relatively high solvent consumption and batch-to-batch vari-
ability [16, 17]. A significant amount of progress has been
made with SPE to substantially reduce solvent consumption
and increase sample throughput, for example the advent of
column-switching systems with on-line extraction, or the
multi-well plate format. Another substantial step was achieved
with SPE miniaturization and the development of new micro-
extraction techniques (solid-based MEs), for example solid-
phase microextraction (SPME), microextraction by packed sor-
bent (MEPS), and stir-bar-sorptive extraction (SBSE), all of
which have several advantages and result in significantly im-
proved sample preparation. The solid-based MEs used in com-
bination with CE are presented in Fig. 2, and all the
bioanalytical applications are listed in Table 2.
Solid-phase microextraction (SPME)
SPME was introduced in 1990 by Arthur and Pawliszyn
[74]. A small amount of sorptive, homogenous, non-porous
extracting phase dispersed on the surface of or inside a solid
support is exposed to the sample for a specific period of time
until equilibrium is reached [75, 76]. The main commercial-
ly used sorbents are polydimethylsiloxane (PDMS) for rath-
er non-polar or volatile compounds and polyacrylate (PA),
PDMS–divinylbenzene (PDMS–DVB), or Carbowax–
divinylbenzene (CW–DVB) for polar compounds. Extrac-
tion can be performed in two main formats: fiber SPME and
in-tube SPME.
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Fiber solid-phase microextraction (fiber SPME)
In fiber SPME, the sorbent (variable film thickness) is
coated on the external surface of a fused-silica fiber tip as
an appropriate polymeric stationary phase. The device, a
modified syringe, consists of a fiber assembly with the
built-in fiber inside the needle and an assembly holder. A
plunger is used to move the coated fiber inside or outside the
needle [19, 77]. Two extraction modes can be used with
fiber SPME: direct immersion of the fiber in the aqueous
sample (DI-SPME) or headspace extraction (HS-SPME),
which was first described in 1993 [78].
Direct-immersion fiber solid-phase microextraction
(DI-SPME)
DI-SPME entails direct immersion of the fiber into the
aqueous sample with consequent stirring, enabling transfer
of non-volatile analytes into the coating [76]. Barbiturates
and benzodiazepines have been extracted by use of a PA-
coated fiber that was immersed in 10 mL urine for 2 h at
60 °C. After extraction, the targeted drugs were desorbed
into 20 μL MeCN for 30 min and analyzed by MEKC on
neutral polyacrylamide-coated capillaries [79, 80].
Headspace fiber solid-phase microextraction (HS-SPME)
HS-SPME has been shown to be advantageous, mainly for
volatile compounds, because of its higher speed, higher
recovery, greater selectivity, longer fiber lifetime, and lower
fiber contamination than for DI-SPME, but it is only suit-
able for highly volatile compounds [76, 81]. Instead of using
a conventional PDMS, PA, or poly(vinyl chloride) fiber,
Zeng and coworkers developed HS-SPME with a calix{4}
arene fiber [82], for propranolol determination, and co-poly
(butyl methacrylate–hydroxy-terminated silicone oil), using
a sol–gel coating, for extraction of ephedrine derivatives in
urine [83]. After a second back-extraction step in a MeCN–
water solution (less than 20 μL MeCN), the analytes were
injected with the FASI stacking method, leading to impor-
tant PFs.
In-tube SPME
In-tube SPME, which was introduced in 1997, was primarily
developed to overcome the inherent problems of fiber SPME,
i.e., fiber fragility, low sorption capacity, and bleeding of fiber
coatings, and to provide an automation option [84]. In this
method, targeted compounds are directly extracted into the
internally coated stationary phase of a fused-silica capillary,
enabling on-line coupling with CE [85]. In-tube SPME is a
type of so-called capillary MEs, which also include open-
tubular trapping, wire-in-tube SPME, fiber in-tube SPME,
sorbent-packed capillary in-tube SPME, and monolithic cap-
illary in-tube SPME [75, 84, 86]. Capillary MEs are distin-
guished from the composition of the extraction stationary
phase (fiber, polymer, sorbent) and its packing [86] and can
be used on-line with CE.
Solid-based
ME
SPME SBSEMEPS
On/in-lineOff-line
Fiber
SPME
In-tube
SPME
DI-SPME HS-SPME
On-line 
SPE-CE
In-line
SPE-CE
Fig. 2 Classification of solid-
based microextractions used
in combination with CE. Light
gray, aqueous phase; cross
hatched, solid support
134 I. Kohler et al.
T
ab
le
2
S
ol
id
-b
as
ed
m
ic
ro
ex
tr
ac
tio
n
te
ch
ni
qu
es
us
ed
in
co
m
bi
na
tio
n
w
ith
C
E
in
bi
oa
na
ly
si
s
A
na
ly
te
(s
)
M
at
ri
x
M
E
S
am
pl
e
vo
lu
m
e
O
rg
an
ic
so
lv
en
t(
s)
O
rg
an
ic
so
lv
en
t(
s)
vo
lu
m
e
A
na
ly
si
s
P
F
/L
O
D
R
ef
.
E
ph
ed
ri
ne
U
ri
ne
,
se
ru
m
M
IP
-S
P
M
E
5
m
L
To
lu
en
e
5
m
L
C
Z
E
–
U
V
0.
96
an
d
1.
1
ng
m
L
−
1
(w
at
er
sa
m
pl
e)
[1
36
]
P
se
ud
oe
ph
ed
ri
ne
E
th
an
ol
7
m
L
M
eO
H
n.
d.
E
ph
ed
ri
ne
de
ri
va
tiv
es
U
ri
ne
H
S
-S
P
M
E
5
m
L
M
eC
N
16
μL
FA
S
I–
C
Z
E
–
U
V
3–
5
ng
m
L
−
1
[8
3]
P
ro
pr
an
ol
ol
en
an
tio
m
er
s
U
ri
ne
H
S
-S
P
M
E
5
m
L
M
eC
N
10
μL
FA
S
I–
C
Z
E
–
U
V
8–
10
ng
m
L
−
1
[8
2]
B
ar
bi
tu
ra
te
s
H
um
an
ur
in
e,
bo
vi
ne
se
ru
m
D
I-
S
P
M
E
3.
5
m
L
–
–
C
Z
E
–
U
V
U
p
to
60
/0
.1
–
0.
3
μg
m
L
−
1
(u
ri
ne
)
an
d
1
μg
m
L
−
1
(s
er
um
)
[1
37
]
B
ar
bi
tu
ra
te
s,
be
nz
od
ia
ze
pi
ne
s
U
ri
ne
D
I-
S
P
M
E
10
m
L
M
eC
N
20
μL
M
E
K
C
–
U
V
<
1
μg
m
L
−
1
[7
9, 80
]
A
m
ph
et
am
in
es
U
ri
ne
M
on
ol
ith
ic
in
-t
ub
e
S
P
M
E
40
μL
M
eO
H
n.
d.
E
K
–
C
Z
E
–
U
V
25
–
34
μg
m
L
−
1
[8
8]
O
pi
at
es
U
ri
ne
M
on
ol
ith
ic
in
-t
ub
e
S
P
M
E
1
m
L
M
eO
H
32
5
μL
E
K
–
C
Z
E
–
U
V
6.
6–
19
.5
ng
m
L
−
1
[8
9]
E
ph
ed
ri
ne
U
ri
ne
,
pl
as
m
a
M
on
ol
ith
ic
in
-t
ub
e
S
P
M
E
1
m
L
M
eO
H
30
0
μL
(M
eO
H
)
LV
S
S
–
C
Z
E
–
U
V
5.
3–
8.
4
ng
m
L
−
1
[9
0]
P
se
ud
oe
ph
ed
ri
ne
M
eC
N
~1
00
μL
(M
eC
N
)
A
ng
io
te
ns
in
II
re
ce
pt
or
an
ta
go
ni
st
s
U
ri
ne
M
on
ol
ith
ic
in
-t
ub
e
S
P
M
E
2
m
L
M
eC
N
50
0
μL
+
B
G
E
C
Z
E
–
U
V
15
–
20
ng
m
L
−
1
[9
1]
P
ro
pr
an
ol
ol
en
an
tio
m
er
s
U
ri
ne
In
-t
ub
e
S
P
M
E
1
m
L
M
eO
H
35
μL
(M
eO
H
)
C
E
C
–
U
V
4
an
d
7
ng
m
L
−
1
[1
38
]
M
eC
N
10
0
μL
(M
eC
N
)
T
ri
cy
cl
ic
an
tid
ep
re
ss
an
ts
U
ri
ne
F
ib
er
-i
n-
tu
be
S
P
M
E
1
m
L
M
eC
N
1.
8-
2.
2
μL
+
B
G
E
C
Z
E
–
U
V
>
10
0/
44
–
15
3
ng
m
L
−
1
[8
7]
C
af
fe
in
e,
pa
ra
ce
ta
m
ol
,
ac
et
yl
sa
lic
yl
ic
ac
id
B
ov
in
e
pl
as
m
a
R
A
M
ca
pi
lla
ry
in
-t
ub
e
S
P
M
E
<
10
μL
M
eO
H
n.
d.
C
Z
E
–
U
V
0.
3–
1.
9
ng
m
L
−
1
[9
2]
PA
H
s
F
is
h
bi
le
S
B
S
E
0.
3
g
M
eC
N
15
0
μL
M
E
K
C
–
U
V
2–
11
μg
m
L
−
1
[9
9]
F
lu
or
oq
ui
no
lo
ne
s
U
ri
ne
M
E
P
S
48
μL
M
eC
N
n.
d.
N
A
C
E
–
E
S
I–
M
S
6.
3–
10
.6
μg
m
L
−
1
[9
6]
M
eO
H
A
ne
st
he
tic
dr
ug
s
P
la
sm
a
M
E
P
S
20
0
μL
M
eC
N
n.
d.
N
A
C
E
–
E
S
I–
M
S
10
.4
–
15
.2
μg
L
−
1
(f
re
e)
[9
5]
M
eO
H
0.
6–
1.
6
ng
m
L
−
1
(t
ot
al
)
O
pi
oi
ds
U
ri
ne
In
-l
in
e
S
P
E
~6
0
μL
M
eO
H
~3
0
nL
(M
eO
H
)
C
Z
E
–
E
S
I–
M
S
0.
01
3–
0.
21
0
ng
m
L
−
1
[1
39
]
i-
P
rO
H
~4
5
μL
(i
-P
rO
H
)
M
et
hi
on
in
e
en
ce
ph
al
in
C
er
eb
ro
sp
in
al
fl
ui
d
In
-l
in
e
S
P
E
3.
2
μL
M
eC
N
40
nL
+
co
nd
iti
on
in
g
(M
eC
N
)
C
Z
E
–
E
S
I–
M
S
40
/1
ng
m
L
−
1
[1
17
]
M
eO
H
~9
0
μL
(M
eO
H
,
S
L
)
E
nk
ep
ha
lin
pe
pt
id
es
C
er
eb
ro
sp
in
al
fl
ui
d
O
n-
lin
e
S
P
E
10
0
μL
M
eC
N
1.
7
μL
(e
lu
tio
n
an
d
ri
ns
e)
C
Z
E
–
E
S
I–
IT
/
M
S
1,
00
0/
1.
5–
3
ng
m
L
−
1
[1
03
]
~2
0
μL
(S
L
)
C
ep
ha
lo
sp
or
in
s
C
ow
pl
as
m
a
O
n-
lin
e
S
P
E
50
μL
M
eC
N
1.
8
μL
C
Z
E
–
U
V
10
0
ng
m
L
−
1
[1
04
]
O
pi
oi
d
pe
pt
id
es
P
la
sm
a
In
-l
in
e
S
P
E
20
0
μL
M
eO
H
~4
0
nL
(M
eO
H
,
el
ut
io
n)
C
Z
E
–
E
S
I–
IT
/
M
S
10
0–
10
,0
00
/0
.1
–
10
ng
m
L
−
1
[1
12
]
i-
P
rO
H
~3
0
μL
(i
-P
rO
H
,
S
L
)
M
eC
N
12
00
μL
(M
eC
N
,
P
P
)
N
eu
ro
pe
pt
id
es
P
la
sm
a
In
-l
in
e
S
P
E
20
0
μL
M
eO
H
~4
0
nL
(M
eO
H
,
el
ut
io
n)
C
Z
E
–
E
S
I–
IT
/
M
S
10
0–
10
,0
00
/0
.1
–
10
ng
m
L
−
1
[1
11
]
i-
P
rO
H
~5
0
μL
(i
-P
rO
H
,
S
L
)
M
eC
N
14
00
μL
(M
eC
N
,
P
P
)
O
pi
oi
d
pe
pt
id
es
P
la
sm
a
In
-l
in
e
S
P
E
20
0
μL
M
eO
H
~4
0
nL
(M
eO
H
,
el
ut
io
n)
tI
T
P
–
C
Z
E
–
T
O
F
/
M
S
U
p
to
5,
00
0/
0.
1
ng
m
L
−
1
[1
13
]
i-
P
rO
H
~1
0
μL
(i
-P
rO
H
,
S
L
)
Microextraction techniques combined with capillary electrophoresis 135
T
ab
le
2
(c
on
tin
ue
d)
A
na
ly
te
(s
)
M
at
ri
x
M
E
S
am
pl
e
vo
lu
m
e
O
rg
an
ic
so
lv
en
t(
s)
O
rg
an
ic
so
lv
en
t(
s)
vo
lu
m
e
A
na
ly
si
s
P
F
/L
O
D
R
ef
.
M
eC
N
14
00
μL
(M
eC
N
,
P
P
)
O
pi
oi
d
pe
pt
id
es
P
la
sm
a
In
-l
in
e
S
P
E
20
0
μL
M
eO
H
<
10
0
nL
(M
eO
H
,
el
ut
io
n)
C
Z
E
–
E
S
I–
IT
/
M
S
10
–
10
0/
0.
1–
1
ng
m
L
−
1
[1
10
]
i-
P
rO
H
<
70
μL
(i
-P
rO
H
,
S
L
)
M
eC
N
14
00
μL
(M
eC
N
,
P
P
)
E
nd
or
m
or
ph
in
s
P
la
sm
a
In
-l
in
e
S
P
E
20
0
μL
i-
P
rO
H
~2
0
μL
(i
-P
rO
H
,
S
L
)
C
Z
E
–
E
S
I–
T
O
F
/
M
S
10
0/
1
ng
m
L
−
1
[1
14
]
M
eC
N
14
00
μL
(M
eC
N
,
P
P
)
N
eu
ro
tr
an
sm
itt
er
s
U
ri
ne
In
-l
in
e
S
P
E
<
1
μL
-
-
C
Z
E
–
U
V
U
p
to
46
2/
3.
7–
4.
3
ng
m
L
−
1
[1
18
]
C
af
fe
in
e
U
ri
ne
In
-l
in
e
S
P
E
<
1
μL
-
-
C
Z
E
–
U
V
1,
50
0–
1,
90
0/
0.
5–
0.
7
ng
m
L
−
1
[1
19
]
E
sc
ita
lo
pr
am
U
ri
ne
In
-l
in
e
S
P
E
<
2.
25
μL
M
eC
N
n.
d.
(M
eC
N
,
B
G
E
an
d
el
ut
io
n)
C
Z
E
–
E
S
I–
T
O
F
/
M
S
10
ng
m
L
−
1
[1
40
]
M
eO
H
~2
5
μL
(M
eO
H
,
S
L
)
S
ul
fo
na
m
id
es
U
ri
ne
,
se
ru
m
O
n-
lin
e
S
P
E
1
m
L
T
H
F
60
0
μL
(T
H
F,
el
ut
io
n)
C
Z
E
–
U
V
0.
05
–
0.
1
μg
m
L
−
1
(u
ri
ne
)
[1
00
]
M
eC
N
20
0
μL
(M
eC
N
,
P
P
)
0.
05
–
0.
3
μg
m
L
−
1
(s
er
um
)
N
S
A
ID
s
U
ri
ne
,
se
ru
m
O
n-
lin
e
S
P
E
1
m
L
M
eC
N
<
1
m
L
(P
P
an
d
el
ut
io
n)
C
Z
E
–
U
V
0.
05
–
0.
1
μg
m
L
−
1
(u
ri
ne
)
[1
01
]
0.
1–
1
μg
m
L
−
1
(s
er
um
)
T
ri
cy
cl
ic
an
tid
ep
re
ss
an
ts
U
ri
ne
,
se
ru
m
O
n-
lin
e
S
P
E
0.
5
m
L
M
eO
H
<
1
m
L
(e
lu
tio
n,
w
as
h,
B
G
E
co
m
po
si
tio
n)
N
A
C
E
–
U
V
40
–
80
ng
m
L
−
1
(u
ri
ne
)
[1
02
]
M
eC
N
60
–
10
0
ng
m
L
−
1
(s
er
um
)
E
nd
og
en
ou
s
bi
om
ar
ke
rs
U
ri
ne
O
n-
lin
e
S
P
E
2.
5
m
L
M
eC
N
<
1
m
L
(e
lu
tio
n,
w
as
h,
B
G
E
co
m
po
si
tio
n)
C
Z
E
–
U
V
0.
14
–
4.
50
μg
m
L
−
1
[1
41
]
M
eO
H
3-
N
itr
ot
yr
os
in
e
R
at
ur
in
e
In
-l
in
e
S
P
E
<
20
0
μL
M
eC
N
n.
d.
C
Z
E
–
U
V
10
0/
4.
4
μm
ol
L
−
1
[1
42
]
M
eO
H
T
ri
az
in
e
he
rb
ic
id
es
U
ri
ne
In
-l
in
e
S
P
E
1
m
L
M
eC
N
~3
0
nL
(M
eC
N
,
el
ut
io
n)
C
Z
E
–
U
V
0.
2–
0.
6
μg
m
L
−
1
[1
15
]
M
eO
H
~1
5
μL
(M
eO
H
,
ri
ns
e)
n.
d.
,
no
t
de
fi
ne
d
L
O
D
is
de
te
rm
in
ed
at
a
si
gn
al
-t
o-
no
is
e
ra
tio
of
3
136 I. Kohler et al.
Fiber in-tube SPME has been used for analysis of four
tricyclic antidepressant drugs (TCAs) in urine [87]. A 10-
mm-long Zylon fiber filling a capillary placed inside a 0.25-
mm i.d. Teflon tube was connected on-line to the CE sys-
tem. After continuous pumping of the sample, TCAs were
desorbed with a few microliters of MeCN, directly trans-
ferred to a cross connector, and separated by CE, leading to
100-fold greater sensitivity.
Feng and co-workers used monolith capillary in-tube
SPME with poly(methacrylic acid–ethylene glycol dimetha-
crylate) for extraction of amphetamines [88], opiates [89],
ephedrine and pseudoephedrine [90], and angiotensin II re-
ceptor antagonists [91] from urine and plasma samples. Some
of these applications were performed with an adapted device
composed of a regular plastic syringe and a monolithic capil-
lary connected by a pinhead (polymer monolith microextrac-
tion, PMME) [89, 91]. In monolith capillary in-tube SPME, a
single piece of monolith with a double-pore structure enables
use of high flow rates with a low generated pressure through
the capillary, leading to high throughput [84, 86]. An alterna-
tive approach is the use of continuous bed RAM in-tube
SPME, which enabled simultaneous protein separation from
the matrix while directly extracting target analytes [92].
Microextraction by packed sorbent (MEPS)
MEPS was developed in 1993 and consists of a 100 to 250-
μL syringe containing 1 to 4 mg of packed sorbent (inserted
into the barrel of the syringe as a plug or between the barrel
and needle as a cartridge). The sorbents are miniaturized to
work with microliter bed volumes, enabling use of sample
and elution volumes as low as 10 μL. All the commercially
available SPE sorbents, including RAM and MIP, can be
used in MEPS [17, 77, 93, 94].
Recently,Morales-Cid et al. used at-line and on-line coupled
MEPS with CE–MS for determination of anesthetic drugs in
plasma [95] and fluoroquinolones in urine [96]. In the first
study, MEPS was performed with a 200-μL syringe containing
4 mg C18 packing. A microdialysis probe was connected to the
needle of the MEPS syringe and the method was fully auto-
mated. Using 200 μL plasma and non-aqueous CE (NACE)
analysis coupled with MS, LODs as low as 10 ngmL−1 were
reported for the free anesthetic drugs [95].
In the second study, the extraction step was directly integrat-
ed into a commercial CE system. The barrel insert and needle
containing 4 mg C18 packing were fitted to the outlet position of
the CE–MS cartridge and connected to a Teflon tube inside the
cartridge working as a reservoir (300 μL) for conditioning,
preconcentration, and elution. Using CE equipment pressures,
samples were preconcentrated and extracted on-line before sep-
aration. Only 48 μL urine and 140 μLMeOHwere required for
conditioning and elution. The eluates were analyzed by NACE-
MS to increase resolution and sensitivity. With this configura-
tion, absolute recovery from urine ranged from 70 to 109%with
LODs of less than 10 ngmL−1 [96].
Stir-bar-sorptive extraction (SBSE)
Based on the same extraction principle as SPME, SBSE was
first developed in 1999 by Baltussen et al. to overcome the
limited amount of extraction sorbent used in SPME [97, 98].
In SBSE, the extraction sorptive phase is coated (0.5 to 1-mm
layer) on to magnetic stir bars (1 to 4 cm in length) composed
of a magnetic rod surrounded by a glass jacket. During stirring
of the aqueous sample (typically 30 to 240 min), analytes are
extracted in accordance with their partition coefficients. De-
sorption can be performed thermally or by liquid desorption
by organic solvent back-extraction.
There have been few applications of SBSE in combination
with CE. Do Rosario et al. developed an SBSE–MEKCmeth-
od for determination of polynuclear aromatic hydrocarbons
(PAHs) in fish bile [99], but no applications in human bio-
analysis have been found. Nonetheless, SBSE could be used
for extraction of urine samples, because of the relatively large
volumes of urine available and the long detection times re-
quired to achieve very low LODs of metabolites. However,
commercial coated stir bars (Twisters; Gerstel, Mühlheim,
Germany) are still limited to PDMS and PDMS–ethylene
glycol phases, which are better suited to extraction of non-
polar compounds.
SPE-CE
Off-line SPE is largely used in combination with CE, because of
its ease of implementation. Over the past two decades, new set-
ups have been developed to automate this process, increase
sample throughput, and reduce solvent consumption. At-line
coupling of SPE with CE is performed with a robotic arm
interface or a modification of the replenishment system. Despite
increased throughput, the same solvent quantities are used for
sample preparation. More advantageous techniques are on-line
and in-line SPE-CE, in which the liquid stream is shared be-
tween SPE and CE and analysis can therefore be achieved with
relatively small volumes of organic solvents.
On-line SPE-CE
In on-line SPE-CE, an interface (vial, valve, or T-piece type) is
used to directly connect the stream from the SPE part and the CE
capillary. Because the SPE process is performed independently
of CE analysis, no adsorption of the matrix components on to
the capillary wall is observed, nor any perturbation of the
electrophoretic process. However, peak broadening can be
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observed because the desorption volume generally larger than
the CE injection volume.
Veraart et al. developed on-line dialysis SPE–CE for analysis
of sulfonamides [100] and NSAIDs [101] in urine and serum.
The system comprised a dialysis unit, four switching valves,
four high-pressure pumps, and a polymer-based SPE column.
When dialysis SPE had been performed, a signal was sent to the
CE system to transfer the analytes that could be analyzed. A
THF–water mixture could be used for analyte desorption to
avoid bubble formation [100] or a MeCN–water mixture could
be used to ensure a good stacking effect during injection [101].
For serum analysis, a PPwithMeCN and decanoic acid was first
performed to disrupt drug–protein bonding. LODs in the ng
mL−1 range were reported for urine samples analyzed by CE–
UV. This dialysis set-up, with NACE, was also used for analysis
of tricyclic antidepressants in urine and serum [102].
More recently, de Jong and co-workers proposed use of
on-line SPE-CE with ion-trap (IT) MS detection for analysis
of peptides in cerebrospinal fluid [103]. Enkephalin peptides
were extracted on C18 sorbent from diluted cerebrospinal
fluid and introduced into the CE system via a valve inter-
face. Less than 2 μL MeCN was necessary for analyte
desorption. The sensitivity was 1,000-fold better than that
obtained by conventional CE–MS. This technique was ap-
plied to a tryptic digest of cytochrome c, and LODs were as
low as 20 nmolL−1, indicating the potential for proteomics.
An alternative on-line SPE–CE–UV procedure was pro-
posed for analysis of antibiotics (cephalosporins) in cow
plasma with a T-split interface [104]. Part of the SPE eluate
was injected and the rest of the sample was flushed to waste
(split ratio 1:40). Before SPE–CE, PP with 10 % perchloric
acid was performed for plasma samples, avoiding the use of
organic solvent, which would reduce the breakthrough vol-
ume on the C18 SPE column or increase the total analysis
time, because of evaporation and reconstitution. With these
conditions, LODs were in the 50–100-ngmL−1 range, sim-
ilar to those reported for other LC–UV methods.
In-line SPE-CE
In in-line SPE-CE, the SPE material is part of the CE capillary,
and the potential is applied on the entire system during separa-
tion using either an open tubular capillary coated with SPE
sorbent, a packed-bed sorbent retained with frits, silica- or
polymer-based monoliths, or an impregnated membrane. Re-
cently, carbon nanotubes, magnetic particles, or antibodies for
immunoaffinity recognition have been successfully investigated.
The overall SPE eluate is analyzed by CE, resulting in good
recovery. Nevertheless, the latter greatly depends on the nature
and volume of the elution solvent. Furthermore, because of
direct transfer of the extraction eluate, adsorption of matrix
components on to the capillary wall can affect the separation
or clog the capillary [105–109].
Sanz-Nebot, Barbosa, and co-workers developed several
applications of CE–ESI–MSwith in-line SPE microcartridges
[110–114]. In their homemade set-up, a CE capillary is cut
into two pieces to enable insertion of an SPE microcartridge.
Its body is coupled to both parts with a 0.5-cm polyethylene
sleeve and equipped with 0.1-cm polyethylene frits after sor-
bent filling. The tight junction obtained means no adhesive
sealing is necessary, and the modified capillary is fitted into
commercial CE cartridges. This approach has been success-
fully applied to the analysis of opioid peptides [110, 112, 113]
and neuropeptides [111] in plasma samples with C18 or other
sorbents [110]. In a recent study, use of an immunoaffinity
sorbent for the analysis of endormorphins in plasma by in-line
SPE–CE–ESI-MS was also evaluated [114]. In this case, the
previously developed microcartridge contained the immu-
noaffinity sorbent consisting of anti-endorphin antibodies that
were covalently attached to activated hydrazide silica particles
via carbohydrate groups. Immunoaffinity sorbents resulted in
improved selectivity and extraction efficiency with a larger
introduced sample volume. LODs as low as 1 ngmL−1 in
standard solutions were achieved with a 100-fold PF com-
pared with CE–MS, and LODs as low as 100 ngmL−1 were
achieved for plasma after PP and filtration. However, some
cross-reactivity against dynorphin, because of non-specific
binding, was also observed.
MIPs, also, are regarded as highly selective synthetic
materials with recognition sites that can specifically bind
target analytes. Molecularly imprinted solid-phase extrac-
tion (MISPE) has been evaluated as an in-line SPE-CE
technique for monitoring of triazine herbicides in urine,
and compared with use of HLB sorbent [115]. MIPs have
several advantages, for example physical robustness, rigid-
ity, resistance to elevated temperature or pressure, and in-
ertness toward organic solvents. The concentrator was
constructed from a 2-mm capillary filled with MIP sorbent
(particle size 55 μm) by use of a vacuum pump and then
introduced into a 1.5-cm piece of PTFE tubing that fitted the
outer diameter of the capillary. No frits were necessary to
retain the sorbent. The results obtained for MIPs were su-
perior to those for HLB sorbent.
Finally, during the last five years, increasing attention has
been paid to the use of monoliths as sorbent in in-line SPE-CE.
Monoliths are rapidly synthesized in one step and are character-
ized by low backpressure and chemical stability over a wide
range of pH. Silica-based (prepared by use of sol–gel technolo-
gy) and polymer-based (prepared by in-situ polymerization of
monomers and cross-linkers) monoliths can be easily fixed at
the end of a capillary by chemical modification [105, 116].
Several in-line SPE–CE applications with a variety of monolith
materials have recently been proposed for analysis of, for ex-
ample, methionine enkephalin in deproteinated cerebrospinal
fluid [117], neurotransmitters (e.g., dopamine, adrenaline, hista-
mine, and serotonin) in urine [118], or caffeine in urine [119].
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Conclusions and future trends
Sample preparation is recognized as the most critical step in
bioanalysis if good accuracy, selectivity, sensitivity, and
robustness are to be achieved. Over the past few decades
significant efforts have been devoted to reducing time, cost,
manual handling, and consumption of solvents and samples.
MEs have been shown to be very attractive compared with
conventional LLE or SPE, and numerous innovative devel-
opments in respect of the liquid phase or miniaturized solid
devices have been proposed. The combination of miniatur-
ized sample preparation with CE has significant potential in
bioanalysis, with only a few microliters of solvent required
for the entire analytical process. Several MEs with CE
analysis have been emphasized in this review, with a variety
of bioapplications. A suitable approach should be selected
considering the physicochemical properties of the analyte,
the nature and volume of the biological matrix, the concen-
tration range of the targeted analyte(s), the selectivity and
sensitivity required, and the possibility of at-line, on-line
and in-line automation.
Future developments will, hopefully, enable CE anal-
ysis to be used with the most recent sample pretreat-
ments, which have already attracted attention in
combination with LC or GC. As examples, disposable
pipette extraction (DPX), in which a loose SPE sorbent
is placed inside a pipette tip [120], was first proposed in
2008 and has already been successfully applied to a
variety of applications with LC or GC analysis and is
also fully adapted to CE analysis. In vivo SPME, in
which sample preparation encompasses less-invasive sam-
pling with direct exposure to human or animal living
systems, could be of great interest in combination with
CE for pre-clinical studies or clinical purposes [121].
Dried-blood spot sampling (DBS) has been shown to be
not only a biofluid support but also a sample pre-
treatment with use of a small amount of solvents, induc-
ing “on support” PP and selective desorption [122–124].
Moreover, recent microextraction techniques (e.g.,
SDME, HS-SDME, DLLME, and HF-LPME) substituting
organic extraction solvents with non-toxic ionic liquids
[125, 126] or natural oils [127] combined with CE could
lead to powerful and solvent-free analytical procedures.
Surprisingly, especially in combination with liquid-based
MEs, very few applications have revealed the potential of
CE hyphenation with MS detection to substantially increase
both sensitivity and selectivity. However, CE–MS is now
easily implemented with dedicated interfaces, either with
addition of a sheath liquid or in the sheathless configuration,
and should undoubtedly be considered in combination with
MEs for all bioanalytical applications to achieve the desired
sensitivity (sub-ngmL−1 range) and provide the possibility
of compound identification.
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